Cardinal Health (CAH)
(Delayed Data from NYSE)
$98.18 USD
-0.17 (-0.17%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $98.22 +0.04 (0.04%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth F Momentum A VGM
Price, Consensus and EPS Surprise
CAH 98.18 -0.17(-0.17%)
Will CAH be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for CAH based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CAH
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
Why Cardinal Health (CAH) is a Top Value Stock for the Long-Term
CAH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Cardinal Health (CAH) Rises As Market Takes a Dip: Key Facts
Why the Market Dipped But Cardinal Health (CAH) Gained Today
Cardinal Health's (CAH) China Syringe Makers Face FDA Warnings
Other News for CAH
$1000 Invested In Cardinal Health 5 Years Ago Would Be Worth This Much Today
Cardinal Health to Announce Fourth-Quarter and Year-End Results for Fiscal Year 2024 on August 14
Cardinal Health price target lowered by $8 at Citi, here's why
Interesting CAH Put And Call Options For March 2025
Cardinal Health: Navigating Inflation with Strategic Mitigation – Outperform Rating & $122 Target